menu
    • menu

    Company profile for Humacyte

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are committed to bringing first-in-class regenerative medicine products to the marketplace that will improve and save the lives of patients worldwide and transform the practice of medicine.Humacyte, Inc., is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company deve...
    We are committed to bringing first-in-class regenerative medicine products to the marketplace that will improve and save the lives of patients worldwide and transform the practice of medicine.Humacyte, Inc., is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HumacyteUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2525 E NC Highway 54, 2525 E Hwy 54, Durham, NC 27713
    Telephone
    Telephone
    919-313-9633
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://humacyte.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/humacyte
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/humacyte

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Humacyte Reveals 2025 Q4 & Year-End Financials, Business Update
    Humacyte Reveals 2025 Q4 & Year-End Financials, Business Update

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263668/0/en/Humacyte-Announces-Fourth-Quarter-and-Year-End-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Humacyte Appoints Rick Mcelheny As Svp Of Business Development
    Humacyte Appoints Rick Mcelheny As Svp Of Business Development

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262930/0/en/Humacyte-Appoints-Rick-McElheny-as-Senior-Vice-President-of-Business-Development.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Humacyte To Report 2025 Q4 Financials And Business Update
    Humacyte To Report 2025 Q4 Financials And Business Update

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260305/0/en/Humacyte-To-Announce-2025-Fourth-Quarter-and-Year-End-Financial-Results-and-Provide-Business-Update-on-March-27-2026.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Humacyte Secures Symvess Approval for Saudi Clinical Program
    Humacyte Secures Symvess Approval for Saudi Clinical Program

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3259008/0/en/Humacyte-Receives-Symvess-Purchase-Commitment-for-Clinical-Evaluation-and-Outreach-Program-in-the-Kingdom-of-Saudi-Arabia.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Humacyte Announces $20M Direct Stock Offering Pricing
    Humacyte Announces $20M Direct Stock Offering Pricing

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258996/0/en/Humacyte-Inc-Announces-Pricing-of-20-Million-Registered-Direct-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Humacyte Files Israeli MAA for Symvess in Trauma Repair
    Humacyte Files Israeli MAA for Symvess in Trauma Repair

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257097/0/en/Humacyte-Submits-Marketing-Authorization-Application-for-Symvess-in-Israel-for-Vascular-Trauma-Repair.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search